January 2025 in “Dermatology Practical & Conceptual” This study found topical finasteride and minoxidil both improved hair loss clinically and trichoscopically more effectively than spironolactone in women with female pattern hair loss.
March 2023 in “Benha Journal of Applied Sciences” This study at Benha University Hospital found that therapies for male androgenetic alopecia are effective and safe based on a randomized trial involving 40 male patients.
September 2019 in “IP Indian journal of clinical and experimental dermatology” This study reported that in women with pattern baldness, hormonal levels and iron deficiency were significantly associated with the condition, but trichoscopic findings were similar across different forms of female pattern hair loss.
1 citations
,
November 2023 in “Journal of Cutaneous and Aesthetic Surgery” This study found that diode laser effectively reduces unwanted facial hair in darker skin types and reported no serious adverse events, suggesting that trichoscopy is an underutilized tool for assessing laser hair reduction outcomes.
62 citations
,
October 2016 in “Dermatologic Therapy” This study found that platelet-rich plasma was more effective for treating alopecia areata than topical 5% minoxidil, leading to earlier hair regrowth and reduction in hair abnormalities.
1 citations
,
December 2024 in “Dermatology and Therapy” This study found that the STRIAA scoring tool provides a rapid and highly reliable assessment of alopecia areata severity, showing a significant correlation with the traditional SALT score, thus enhancing clinical evaluation in patients with this condition.
January 2024 in “Dermatology practical & conceptual” In this study, researchers evaluated factors influencing alopecia areata recurrence and identified male gender and a family history of the condition as independent predictors for disease recurrence among the 100 patients analyzed.
October 2021 in “Indian Journal of Plastic Surgery” This article reviews the use of trichoscopy for differentiating mimickers of patterned hair loss and assessing donor sites in hair transplant patients, without providing new clinical findings.
4 citations
,
February 2021 in “International Journal of Women's Dermatology” This study determined that trichoscopy is a sensitive and specific tool that effectively aids in diagnosing alopecia in women, especially when clinical diagnosis is uncertain.
September 2021 in “International Journal of Epidemiology” This study found that the main causes of diffuse hair loss in adult women were female pattern hair loss, telogen effluvium, chronic telogen effluvium, and a combination of female pattern hair loss with telogen effluvium.
July 2026 in “Dermatology Practical & Conceptual” In this study, pediatric hair and scalp disorders were effectively diagnosed using trichoscopic and light microscopic examinations, demonstrating high agreement with clinical diagnoses and emphasizing their utility as reliable, non-invasive diagnostic tools in a hospital-based setting.
1 citations
,
October 2024 in “Dermatology Practical & Conceptual” This study suggests that RCM may be a promising non-invasive diagnostic tool for alopecia areata incognita, showing substantial agreement with histopathology while noting some discrepancies.
1 citations
,
December 2022 in “Journal of cosmetic dermatology” This study found that combining a potent steroid with a vitamin D analogue may offer more convenient treatment for localized alopecia areata than using a superpotent steroid alone, with comparable efficacy but fewer side effects.
5 citations
,
December 2023 in “Journal of the European Academy of Dermatology and Venereology”
4 citations
,
April 2022 in “Dermatologic Therapy” This study found that using autologous micrografts from scalp tissues significantly improved hair thickness and density in patients experiencing telogen effluvium following COVID-19, with notable improvements observed over a 6-month follow-up period.
April 2026 in “Academic Dermatology” In this retrospective observational study, researchers found that the Dean Scale showed better diagnostic accuracy than the CTCAE scale for detecting clinician-reported therapeutic responses to minoxidil in patients with anticancer therapy-induced alopecia, but both scales had limitations in recording clinically significant hair regrowth.
January 2026 in “Dermatologic Therapy” In this prospective study, ritlecitinib effectively reduced hair loss in patients with severe alopecia areata, with 43.3% of participants achieving a 20 or lower SALT score by week 24, and showed a good midterm safety profile.
August 2020 in “International Journal of Medical Arts (Print)” This study found that topical cetirizine 1% may be effective in treating androgenetic alopecia in men, with some patients experiencing new hair growth compared to none in the placebo group.
1 citations
,
January 2017 in “International Journal of Dermoscopy” This study observed that dermoscopy is a valuable tool for hair transplant surgeons to evaluate and improve the aesthetic outcomes and address technical errors in transplant procedures.
October 2023 in “European medical journal. Dermatology” This review outlines a systematic approach for dermatologists to accurately diagnose hair loss disorders, emphasizing the importance of differentiating between scarring and non-scarring alopecia to guide appropriate treatment decisions.
February 2026 in “Clinical Traditional Medicine and Pharmacology” In this study, both Unani formulations tested were effective in managing Telogen Effluvium, with Itrifal Kishneezi and Roghan Amla showing slightly faster early results in reducing hair shedding, although overall efficacy between the two treatments was comparable.
April 2024 in “Diagnostics” In this study, researchers found that 68% of orthodontic patients with oligodontia displayed hair disorders, such as hypotrichosis and androgenetic alopecia, highlighting trichoscopy and trichogram as valuable diagnostic tools to distinguish between isolated and syndromic forms of the condition.
69 citations
,
August 2014 in “Journal of The American Academy of Dermatology” This review discusses recent advances in trichoscopy for differentiating types of alopecia and presents a systematic approach for using its diagnostic findings, but reports no new clinical results.
The researchers observed that in cases of alopecia areata with atypical features, histopathological confirmation may be necessary, as trichoscopic clues like loss of follicle ostia and vellus hairs were common, while typical features such as exclamation mark hairs were not always present.
December 2024 in “http://isrctn.com/” MpowerTM may improve hair growth and satisfaction more than plain minoxidil, with mild side effects.
86 citations
,
August 2014 in “Journal of The American Academy of Dermatology” This article discusses the history taking and clinical examination process for diagnosing alopecia and outlines a diagnostic approach, noting that it reports no new clinical results.
October 2015 in “CRC Press eBooks” This article reviews the use of trichoscopy for diagnosing and monitoring various scalp conditions, but it presents no new experimental findings; the authors emphasize its precision in noninvasive evaluation.
September 2014 in “Turkish Journal of Dermatology” This study found that non-scarring acquired alopecias were the most common hair and scalp diseases among children visiting a pediatric dermatology outpatient clinic.
5 citations
,
December 2018 in “Journal of Cosmetic Dermatology” This study found that after treatment with platelet-rich plasma, male androgenetic alopecia patients showed significant improvements in hair count, hair diversity, and reduction in certain dermoscopic features.
This review discusses various non-invasive methods for diagnosing alopecia areata, highlighting that trichoscopy signs like short vellus hairs and yellow dots are sensitive indicators of the condition, while advanced imaging techniques provide valuable information on hair follicle status and scalp inflammation.